Please login to the form below

Not currently logged in
Email:
Password:

GSK’s finance SVP joins Parexel International

Simon Harford becomes chief financial officer

Pharmaceutical services provider Parexel International has appointed Simon Harford as chief financial officer and senior vice president from 1 June.

Harford joins from GlaxoSmithKline, where he most recently served as senior vice president of finance, based at the pharma firm's global headquarters in the UK.

Prior to joining GSK in 2009, Harford served as group vice president and controller at cosmetics firm Avon, having previously spent two decades at Eli Lilly in a number of roles including chief financial officer for its EMEA operations.

Josef von Rickenbach, chairman and chief executive of Parexel, said: “Simon brings to Parexel more than three decades of global financial management and investor relations experience in the pharmaceutical industry.

“Simon's leadership will strengthen our ability to accelerate growth and improve profitability as we implement our corporate strategy.”

7th March 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....